Approval was based on the phase 3 ENERGIZE and ENERGIZE-T studies evaluating the safety and efficacy of mitapivat in adults with alpha- or beta-thalassemia.

Doher Drizzle Pablo was drowning in travel receipts. After her company transferred her to Sweden from the Philippines last year, she’d started visiting clients in at least two countries a month, and ...

Why is vibe coding is called vibe coding? Vibe coding is a methodology in software development where the traditional act of writing code gives way to conversational instructions and collaboration with ...

Experts offered pointers on appropriate use of iron therapies, erythropoiesis stimulating agents (ESAs), and hypoxia inducible factor inhibitors (HIF-PHI) for anemia of chronic kidney disease (CKD).

In the decades since the human genome was first sequenced, scientists have repeatedly and boldly declared that “the concept of race has no genetic or scientific basis.” 1 Yet medical and research ...

While letting AI take the wheel and write the code for your website may seem like a good idea, it’s not without its limitations. MIT Technology Review Explains: Let our writers untangle the complex, ...

Have you ever wished you could skip the repetitive, time-consuming parts of coding and get straight to the creative, problem-solving aspects? If you’ve spent hours debugging or manually writing ...

Whether you are a beginner or an expert looking to enhance your programming skills, there are plenty of free and premium websites that can help you learn programming. These websites offer live code ...

Forbes contributors publish independent expert analyses and insights. Rachel Wells is a writer who covers leadership, AI, and upskilling. Learning to code is not exclusively just for software ...

Heavy or prolonged periods can cause iron deficiency anemia. Anemia may impact periods, but this requires further research. Iron deficiency anemia occurs if people do not have enough iron in the body ...

The NCCN has updated its guidelines to recommend imetelstat as a top treatment for symptomatic anemia in lower-risk MDS, following its FDA approval based on encouraging phase 3 trial results. The ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that ...